Medical Care Technologies Inc.
MDCE
$0.0003
$0.000.00%
OTC PK
| 09/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -35.04% | -94.21% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -35.04% | -94.21% | |||
| Cost of Revenue | -59.61% | -97.88% | |||
| Gross Profit | 20.96% | 100.69% | |||
| SG&A Expenses | -69.47% | -48.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -62.95% | -88.59% | |||
| Operating Income | 606.09% | 85.53% | |||
| Income Before Tax | 558.60% | 84.76% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 558.60% | 84.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 558.60% | 84.76% | |||
| EBIT | 606.09% | 85.53% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -- | -- | |||
| Normalized Basic EPS | -- | -- | |||
| EPS Diluted | -- | -- | |||
| Normalized Diluted EPS | -- | -- | |||
| Average Basic Shares Outstanding | -- | -- | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||